<img height="1" width="1" style="display:none;" alt="" src="https://analytics.twitter.com/i/adsct?txn_id=l4xqi&amp;p_id=Twitter"> <img height="1" width="1" style="display:none;" alt="" src="//t.co/i/adsct?txn_id=l4xqi&amp;p_id=Twitter">


Build Brand and Credibility in the
Healthcare Technology and Innovation Field

Target Audience

Healthcare providers and executives, tech enthusiasts, and entrepreneurs looking for advice on creating and growing a business

About epharmix

Epharmix is an unobtrusive remote patient monitoring app that uses mobile interventions to collect patient-reported data and help patients get to goals faster while reducing the workload for providers. Epharmix uses automated phone calls or text messages to collect disease-specific data, analyze the collected data to triage entire patient panels, and send actionable tasks to medical staff.

Goals With Influence & Co.


Introduce Epharmix to a larger audience and increase company and thought leader visibility among that audience by landing contributions in three impressive publications.


Increase Epharmix’s visibility among a new audience of entrepreneurs and aspiring entrepreneurs, allowing Epharmix to share its journey of entrepreneurial success with an audience that will find it inspiring and aspirational.


Build Epharmix’s brand and credibility within the tech field with a specific focus on healthcare technology and innovation.


blake marggraff

CEO at Epharmix

"The Influence & Co. team balanced a consultative, customized approach with cost-effective execution. Our team helped set the direction, and Influence & Co. quickly and professionally delivered content that has helped position Epharmix as a thought leader in digital health."

Our partnership and Problems to solve

Epharmix partnered with us to create thought leadership content that would help establish the company as an industry leader among doctors, physicians, and chief medical officers in healthcare tech and position its CEO as an expert in clinical research related to Epharmix's product. Epharmix wanted to create content that would not only hit these points, but also aid in facilitating relationships with entrepreneurs, future investors, and possibly new employees.

Highlight Content






In order to achieve these goals, we focused on creating two guest-contributed articles per month, targeting key publications that Epharmix's audience of healthcare professionals, tech enthusiasts, and entrepreneurs read. The cadence of two articles per month helped establish consistency in the brand’s content, emphasizing predictions and obstacles within the healthcare industry and how startups and entrepreneurs can effectively grow their businesses. It also showcased Epharmix's CEO’s knowledge on what to expect within the entrepreneurial journey and how the industry of healthcare can be enhanced by the advances of tech.


Through our partnership, Epharmix has published more than 22 pieces of content across 15 publications (including Entrepreneur, Tech.Co, Health IT Outcomes, MedCity News, and Becker's Hospital Review),earning more than 3,000 social shares and reaching an audience of more than 8 million readers on social platforms.

Robust portfolio


Through these efforts, Epharmix was able to create 14 medically focused and three tech-focused and entrepreneurship-focused pieces of guest-contributed content that targeted each key audience group.

social engagement


"More Than Money: How the Right Investor Can Add Lasting Value to Your Startup," an Entrepreneur article to which Epharmix contributed, received more than 1,000 social shares, which is 31.4 percent higher than the average number of shares an article receives at that publication.

recruitment and investment fuel


Epharmix was able to leverage its various pieces of guest-contributed content and use them as resources in recruitment efforts and investment and entrepreneurial relationships efforts.


How Can We Help You?

Are you interested in working with Influence & Co. to turn your expertise into influence? Fill out this form, and our team will be in touch with you.